| mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
7e-06 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-05 |
| mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
3e-05 |
| mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
3e-05 |
| mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
6e-05 |
| mRNA |
AT-7519 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
9e-05 |
| mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0001 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
0.0001 |
| mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
0.27 |
0.0001 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0002 |